Bleeding Eye Virus: What Is The Deadly “Bleeding Eye Virus”?
Bleeding Eye Virus: After approximately five days of fever, the virus begins damaging the patient’s blood vessels, which can lead to internal bleeding, psychological symptoms such as confusion and aggression, and continuous bleeding from the nose, gums, vagina, eyes, mouth, or ears.
Public health officials worldwide are closely monitoring the spread of a deadly virus ominously referred to as the “Bleeding Eye Disease.” But what exactly is this virus?
Bleeding Eye Virus, According to an update from Rwanda’s Ministry of Health, as of November 29, at least 66 individuals have contracted the Marburg virus disease (MVD), with 15 fatalities reported.
The Marburg virus, which is often fatal and related to the better-known Ebola virus, is sometimes called the “Bleeding Eye Disease” because it damages blood vessels and can cause bleeding from various body openings, including the eyes.
Bleeding Eye Virus, In October, the World Health Organization (WHO) issued a travel warning regarding Rwanda. Meanwhile, the UK National Public Health Organization advised travelers to Rwanda to avoid activities such as attending funerals or interacting with wild animals.
Rwandan authorities reported that the outbreak appears to have slowed, with no new cases recorded for 28 days as of November 29 and a gap of 22 days since the last patient was discharged from the hospital. However, the disease’s incubation period is notably long.
Bleeding Eye Virus, Despite this, the Marburg virus, alongside emerging cases of Mpox (formerly known as monkeypox) identified in the UK and California, remains one of several viruses causing concern among global health experts in recent weeks.
A Deadly Twin To Ebola
Bleeding Eye Virus, Scientists first identified the Marburg virus in 1967 following outbreaks in Marburg and Frankfurt, Germany, and Belgrade, the former capital of Yugoslavia.
The virus belongs to the Filoviridae family, which also includes the deadly Ebola virus. According to the UK government-operated website Travel Health Pro, the two viruses are clinically almost indistinguishable.
It is believed that Marburg virus is typically transmitted to humans through fruit bats and can remain dormant in a person’s body without symptoms for up to 21 days (averaging 5 to 9 days).
Bleeding Eye Virus, After about five days of fever, patients begin experiencing blood vessel damage, which can lead to internal bleeding, psychological symptoms such as confusion and aggression, and continuous bleeding from the nose, gums, vagina, eyes, mouth, or ears.
Without treatment, the disease is usually fatal, with an estimated mortality rate of around 62%. This is partly why the WHO has classified the Marburg virus as a disease with high pandemic potential.
Efforts To Combat The Virus
Bleeding Eye Virus, Although no specific antiviral treatment has been proven effective, a potential vaccine is under investigation. As part of a clinical trial, over 1,500 Rwandan healthcare workers have received this vaccine.
In addition to Marburg, health authorities are also concerned about new cases of Mpox, which continue to surface in regions such as the UK and California, adding to the global health community’s challenges in managing infectious diseases.
What Is The Deadly “Bleeding Eye Virus”?
Bleeding Eye Virus, After approximately five days of fever, the virus begins damaging the patient’s blood vessels, which can lead to internal bleeding, psychological symptoms such as confusion and aggression, and continuous bleeding from the nose, gums, vagina, eyes, mouth, or ears.
Public health officials worldwide are closely monitoring the spread of a deadly virus ominously referred to as the “Bleeding Eye Disease.” But what exactly is this virus?
Bleeding Eye Virus, According to an update from Rwanda’s Ministry of Health, as of November 29, at least 66 individuals have contracted the Marburg virus disease (MVD), with 15 fatalities reported.
The Marburg virus, which is often fatal and related to the better-known Ebola virus, is sometimes called the “Bleeding Eye Disease” because it damages blood vessels and can cause bleeding from various body openings, including the eyes.
Bleeding Eye Virus, In October, the World Health Organization (WHO) issued a travel warning regarding Rwanda. Meanwhile, the UK National Public Health Organization advised travelers to Rwanda to avoid activities such as attending funerals or interacting with wild animals.
Rwandan authorities reported that the outbreak appears to have slowed, with no new cases recorded for 28 days as of November 29 and a gap of 22 days since the last patient was discharged from the hospital. However, the disease’s incubation period is notably long.
Despite this, the Marburg virus, alongside emerging cases of Mpox (formerly known as monkeypox) identified in the UK and California, remains one of several viruses causing concern among global health experts in recent weeks.
A Deadly Twin To Ebola
Bleeding Eye Virus, Scientists first identified the Marburg virus in 1967 following outbreaks in Marburg and Frankfurt, Germany, and Belgrade, the former capital of Yugoslavia.
The virus belongs to the Filoviridae family, which also includes the deadly Ebola virus. According to the UK government-operated website Travel Health Pro, the two viruses are clinically almost indistinguishable.
It is believed that Marburg virus is typically transmitted to humans through fruit bats and can remain dormant in a person’s body without symptoms for up to 21 days (averaging 5 to 9 days).
Bleeding Eye Virus, After about five days of fever, patients begin experiencing blood vessel damage, which can lead to internal bleeding, psychological symptoms such as confusion and aggression, and continuous bleeding from the nose, gums, vagina, eyes, mouth, or ears.
Without treatment, the disease is usually fatal, with an estimated mortality rate of around 62%. This is partly why the WHO has classified the Marburg virus as a disease with high pandemic potential.
Efforts To Combat The Virus
Bleeding Eye Virus, Although no specific antiviral treatment has been proven effective, a potential vaccine is under investigation. As part of a clinical trial, over 1,500 Rwandan healthcare workers have received this vaccine.
Bleeding Eye Virus, In addition to Marburg, health authorities are also concerned about new cases of Mpox, which continue to surface in regions such as the UK and California, adding to the global health community’s challenges in managing infectious diseases.
Also Read:
Breakthrough Drug For Rare Eye Cancer Now Accessible In The UK
4 Tips For Improve Vision Naturally: Can Eye Exercises Improve Vision Problems?